Skip to main content

ASP Isotopes Inc.

corporate_fare Company Profile

ASP Isotopes Inc.

ASPI·NASDAQ·Industrial Applications And Services·CIK 0001921865

ASP Isotopes Inc. is an advanced materials company focused on developing an isotope enrichment platform to provide critical materials for nuclear medicine, next-generation semiconductors, and nuclear energy. In January 2026, the company acquired Renergen, which is South Africa's leading onshore natural gas explorer and the first integrated producer of both liquid helium and LNG. The company's proprietary enrichment technologies, the Aerodynamic Separation Process ("ASP technology") and Quantum Enrichment technology ("QE technology"), are designed to produce isotopes for industrial and advanced technology applications. ASP Isotopes Inc.'s initial focus for its isotope enrichment platform is on the production and commercialization of enriched Carbon-14 ("C-14"), Silicon-28 ("Si-28"), and Ytterbium-176 ("Yb-176"). Commercial production of enriched isotopes began at both of its ASP enrichment facilities in Pretoria, South Africa, during the first half of 2025. The first ASP enrichment facility is designed to enrich light isotopes like C-14 and C-12. The second ASP enrichment facility, which is substantially larger, is designed to enrich kilogram quantities of heavier isotopes, including Si-28. The company is producing commercial samples of highly enriched Yb-176 at its third enrichment facility, a QE technology facility and its first laser-based enrichment plant. The company is planning additional isotope enrichment plants in South Africa and other jurisdictions, including Iceland and the United States. The C-14 produced using ASP technology may be used in new pharmaceuticals and agrochemicals, while Si-28 produced using ASP technology may be used in advanced semiconductors and quantum computing.

ASP Isotopes Inc. (NASDAQ:ASPI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors ASPI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • ASP Isotopes Appoints Renergen Executives as President and Co-COO, Grants $10.6M in Inducement Equity
  • ASP Isotopes Completes Renergen Acquisition, Secures $750M Debt Funding for Helium Expansion

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$23.85M
Net Income
-$159.84M
Diluted EPS
-$2.11
Op. Cash Flow
-$37.78M
Free Cash Flow
-$47.43M
Gross Profit
$3.4M
Operating Income
-$59.91M
Cash & Equivalents
$285.56M
Total Debt
$14.36M
Debt / Equity
0.07×
Net Margin
-6.70×
Shares Outstanding
111.68M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197329
$6.63 +0.08% today
52-week range · as of 2026-05-26 $3.92 – $14.49
Market cap
$824.67M
Volume
5.2M (0.9× avg)
3-mo avg 5.7M
Live data · 2026-06-14 08:41 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ASPI - Filings & News (Page 2)

ASPI
Jan 12, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.59
Real-time Price: $6.63 info
Change: -$0.960 (-13%) info
Market Cap: $824.668M info
ASPI
Jan 07, 2026, 9:28 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.35
Real-time Price: $6.63 info
Change: +$0.280 (+4%) info
Market Cap: $824.668M info